Next Article in Journal
Energetic and Biomechanical Contributions for Longitudinal Performance in Master Swimmers
Previous Article in Journal
A Systematic Review of the Effects of Exercise on Hormones in Women with Polycystic Ovary Syndrome
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Craniomandibular Disorders in Pregnant Women: An Epidemiological Survey

by
Grazia Fichera
1,
Alessandro Polizzi
1,*,
Simone Scapellato
1,2,
Giuseppe Palazzo
1 and
Francesco Indelicato
1
1
Department of General Surgery and Surgical-Medical Specialties, University of Catania, 95124 Catania, Italy
2
Department of Biomedical, Odontostomatological Sciences and of Morphological and Functional Images, University of Messina, 98125 Messina, Italy
*
Author to whom correspondence should be addressed.
J. Funct. Morphol. Kinesiol. 2020, 5(2), 36; https://doi.org/10.3390/jfmk5020036
Submission received: 6 April 2020 / Revised: 28 May 2020 / Accepted: 1 June 2020 / Published: 4 June 2020
(This article belongs to the Section Sports Medicine and Nutrition)

Abstract

:
Temporomandibular joint (TMJ) disorder has been reported to be 1.5 to two times more common in women than men. Such a gender-based difference could be attributed to behavioral, hormonal, anatomical, and psychological characteristics. Physiological hormonal differences between genders could be one of the possible explanations for the higher incidence of temporomandibular disorder (TMD) in women. As the plasma level of certain female hormones increases during gestation, it could be assumed that there is a higher prevalence of dysfunctional signs and symptoms in pregnant women. We performed an epidemiological survey based on screening for TMD in a group of 108 pregnant women and found that 72% of young women reported significant signs of TMJ disorders, 9% of the young women reported mild signs of TMJ disorders, and 19% of the included subjects reported no signs or symptoms of TMD. The presence of estrogen receptors in the temporomandibular joint of female baboons could be the basis of an explanation for the increased prevalence of dysfunction in young women reported in the literature and the high feedback we have seen of joint noises in pregnant women. On the basis of the present findings, it could be assumed that gestation period could represent a risk factor for craniomandibular dysfunctions.

1. Introduction

Dysfunction of the masticatory system, including the temporomandibular joint (TMJ), muscular and dental system, and the supporting bones, is called temporomandibular disorder (TMD) [1].
Adults are more affected by TMD as compared with children in a range of between 40% and 70%, however, a relevant high incidence of TMD has been found among subjects in mixed dental dentition [1,2,3]. Ethnicity, age, geographical location, and time of assessment influence the prevalence, causes, and factors that affect TMD, as well as the signs and clinical symptoms [4,5,6,7]. According to previous findings, TMD is generally reported to be 1.5 to two times more common in women as compared with men, and this difference is attributed to behavioral, hormonal, anatomical, and psychological factors [8,9]. In general, women are more affected than men by craniomandibular dysfunctions with a ratio of 4 to 1 [10,11,12,13,14]. The prevalence of clicks, headaches, teeth tightening, hypomobility, difficulty in chewing, and neuromuscular symptoms has been shown to be significantly higher among young women (<30 years) [15,16,17,18,19,20]. Moreover, there was a significant correlation between the severity of symptoms and age among women, and a relative reduction in clinical symptoms with age in both sexes [10,11,12,13,15,16,21,22]. Previous evidence reported that estrogen receptors are localized in the TMJ tissues, such as chondroid tissue of condyle and retrodiscal tissues [6,17,18,23,24,25,26,27]. In this respect, the hormone, estrogen, could influence the incidence of TMD, and its levels can affect the development, restitution, and metabolism of the temporomandibular joint, bone, and associated structures [7,23,25,28,29,30,31,32,33,34]. Estrogen can be related to TMD by regulating the pain mechanisms in the expressions of TMD [35]. For example, receptors for estrogens were found in both the peripheral and central nervous systems which would suggest that estrogens are capable of modifying pain signaling [36]. Moreover, estrogen receptors (ERα, ERβ) were also reported in the dorsal root ganglion (DRG) and in the trigeminal nerve nucleus. Estrogen can act as a pro- and anti-nociceptive, depending on the pain signaling type. In physiological pain, estrogen decreases pain, whereas, in inflammatory pain, the effect of estrogen depends on the inflammation type. In acute inflammatory pain, estrogen has an anti-nociceptive effect. On the contrary, in chronic inflammatory pain, this hormone has been documented to have a pro-nociceptive effect due to the presence of its receptors in tissues of both the peripheral and central nervous systems [36,37,38,39].
Thus, physiological hormonal differences between males and females could be one of the possible explanations for the higher incidence of TMD in the female. Given that the plasma level of some female hormones increases during gestation, it could be postulated that there is a higher prevalence of dysfunctional signs and symptoms in pregnant women than the frequencies reported in the literature for the same sex. In this respect, the aim of the present study was to assess the presence of TMJ disorders in a cohort of pregnant women.

2. Materials and Methods

2.1. Study Design

This study followed the Helsinki Declaration on medical protocols and ethics and received positive response by the Approval Board of the School of Dentistry, University of Catania (protocol no. 14/19). The study sample included subjects followed at a private practice specialized in gynecology and gynecologic radiology, in Catania (Italy), between January 2016 and March 2020. For the investigation, subjects were recruited base on the following inclusion criteria: subjects at the sixth month of pregnancy, aged between 19 and 35 years, and absence of severe dental pathology potentially affecting the perception of TMD and craniofacial dysmorphism. The anamnestic data were collected using yes-no questionnaires in compliance with the Helkimo anamnestic dysfunction index (Ai) (Figure 1) and subjects were classified as Ai 0 (no symptoms), I (mild symptoms), and II (severe symptoms) based on the information obtained.
Screening for craniomandibular dysfunctions was done by following the Helkimo dysfunction index guidelines (Figure 2) [40,41,42].
All examinations were performed by the same expert, blinded gnathologist. In particular, clinical examination of masticatory apparatus was performed using the Helkimo clinical dysfunction index (Di), which is based on five domains each evaluating one of the following signs of TMJ dysfunction: limited TMJ mobility, limited TMJ function, jaw muscle pain to palpation, TMJ pain to palpation, and pain during mandibular movement. Jaw movements were evaluated in order to highlight the presence of any limitations. The temporomandibular joint was examined for the diagnosis of joint noise, taking into account possible deviations and deflections of the lower median line over three chewing cycles. Palpation of the chewing muscles and the temporomandibular joint was carried out, and the mandible excursions were examined to assess the presence of pain. Scores for each of the domains were based on the three-level scale of severity, i.e., 0 (no symptoms), 1 (mild symptoms), and 5 (acute symptoms) and were summed up to obtain a total dysfunction score ranging from 0 to 25 points, with a high score indicating a higher temporomandibular dysfunction. In order to obtain comparative assessment, data of the study group were matched with a control sample of female subjects living in the same geographic area who had been referred to the same gynecology clinic for routine controls. The recruitment of the control group was based on the same inclusion criteria as the study group except for the pregnancy status.

2.2. Power Sample Analysis

A preliminary evaluation of sample size power was performed on 20 subjects (10 in the study group and 10 in the control group), the analysis suggested that 79 patients for each group were required to reach the 80% power to detect a mean difference of 7.2% [43] of incidence of clinically assessed joint click between study and control groups, with a confidence level of 95% and a beta error level of 20%. However, according to the inclusion criteria, it included 108 subjects in the study group and 90 subjects in the control group which increased the robustness of the data.

2.3. Statistical Analysis

The Kolmogorov–Smirnov test was preliminarily performed to test the normality of the data. Since the data showed homogeneous variance, parametric tests were used to evaluate and compare measurements.
For those subjects reporting positive values from the anamnestic index, data obtained from the dysfunction index were recorded on a specific spreadsheet. Datasets were analyzed using SPSS® version 24 Statistics software (IBM Corporation, 1 New Orchard Road, Armonk, New York, USA). The incidence of TMD was detected as percentage values within the sample size. Chi-square test coefficient was used to compare the distribution data obtained from the anamnestic and dysfunction forms between each group. The level of significance was set at p < 0.05.

3. Results

One hundred and eight pregnant females (mean age 27.4 ± 3.8) were finally recruited to participate in the survey of the present investigation and 72% of young women reported significant signs of TMJ disorders. Thus, they were allocated to belong to the DII group (moderate dysfunctional) according to the anamnestic Helkimo index; 9% of young women reported slight signs of TMJ disorders and were allocated to the DI group (slightly dysfunctional). Consequently, 19% of the included subjects did not report signs or symptoms of TMD and were allocated to the the D0 group.
Ninety female subjects were enrolled in the control group (mean age 26.2 ± 4.5) and 41% of young women reported significant signs of TMJ disorders. Thus, they were allocated to the DII group (moderate dysfunctional) according to the anamnestic Helkimo index; 11% of young women reported slight signs of TMJ disorders and were allocated to the DI group (slightly dysfunctional). Consequently, 48% of the included subjects did not report signs or symptoms of TMD and were allocated to the D0 group.
Table 1 shows the distribution of data obtained with the anamnestic Helkimo index and assessed using the Chi-square test (p < 0.05). Table 2 shows the distribution of data obtained with the Helkimo dysfunction index and assessed using the Chi-square test. In both groups, all subjects in the DII group reported TMJ click, whereas subjects in the DI group reported muscular pain (p < 0.05).

4. Discussion

From the literature review, it can be seen that the incidence of craniomandibular dysfunctions, except for a few exceptions, shows no gender differences in school-age patients, whereas, for adults, prevalence of signs is observed dysfunctional in the female sex. It can be hypothesized with great certainty that, after adolescence, physiological, psychological, and morphological differences are taking over. With regard to physiological differences, in addition to the effects of hormonal regulation of metabolic activities, women are much more susceptible to pulp stimulation pain. Men tolerate deep pain much more readily than women, and pain tolerance in general and the threshold of skin pain are lower in women than in men [44,45,46].
Patients with craniomandibular dysfunction, and especially women, similar to periodontitis [28,47,48,49,50,51,52,53] have a lower pain tolerance than the control group [42,54], and a lower pain threshold [55,56]. In addition, emotional stress increases pain by accelerating activities in the neural system, which is, in turn, stimulated by harmful impulses. Anxiety, depression, anger, induce autonomous, visceral and skeletal activities, and the interactions between these biological systems are illustrated in the pain-anxiety-tension cycle proposed by some authors to explain some forms of acute pain, and often observed in pathologies affecting the skeletal-muscular system [57,58,59,60,61].
Pain causes anxiety, which induces both prolonged muscle spasms at pain sites and trigger points, as well as vasoconstriction, ischemia, and release of pain-mediating substances. Similarly, depression has a profound effect on peripheral symptoms, interacting through the thalamus and hypothalamus. Catecolo-methyltransferases (COMT) is an important enzyme that inactivates neurotransmitters and regulators of the central and peripheral nervous system. Patients with craniomandibular dysfunction have a low erythrocyte level of COMT as compared with control subjects, and therefore appear to be predisposed to depression. With a few exceptions, women suffer much more than men from depression and this psychophysiological difference could explain the results of his studies [62].
Depression is easier to match among young women and usually decreases with age; however, symptoms of depression are less common among young males [24]. This could justify the significant correlation between the severity of symptoms and age for women, and the decrease in the number of symptoms for both sexes previously found [21,63,64]. The authors also saw that young women have a high incidence of clicks, headaches, teeth tightening, hypomobility, difficulty in chewing, and neuromuscular symptoms. This could be explained by the fact that women are much more susceptible to tissue alterations and, in particular, to those of the condyle-disc complex [24,64].
The teeth tightening found in young women would represent a functional expression of specificity of response originating from the activity of large muscles and high residual muscle tension. Chronic muscle hyperactivity with the maintenance of high residual muscle tension could initiate numerous pathophysiological mechanisms [49,65,66,67].
It must also be said that women from puberty to menopause have a hormonal structure that varies cyclically in a physiological way. During pregnancy, this situation changes further, as, after fertilization, the lute body remains active, magnifying large amounts of estrogen and progesterone. After the third month, it is no longer essential for the continuation of pregnancy, as its endocrine function changes to the placenta, so it regresses. The placenta, as well as an organ responsible for the exchanges between the fetus and the mother, is also an endocrine organ, which separates at least four types of hormones, i.e., a gonadotropin, estrogen, progesterone, and relaxin [67]. The effects of sex hormones in target tissues are varied and very significant. They stimulate collagen and protein synthesis, increased vasal reactivity, alteration of endothelial permeability, and prostaglandins synthesis [67,68,69,70]. They also have an effect on the immune system, having a role in antibody formation and in stem cell differentiation and proliferation. They inhibit leucocyte proliferation in rats and, in humans, suppress the transformation of lymphocytes. Estrogens also tend to increase the immune response, as opposed to androgens [71].
The presence of estrogen receptors in the temporomandibular joint of female baboons [16,71] could be the basis of an explanation for the higher prevalence of the dysfunction in young women reported in the literature [72,73,74,75,76,77,78,79,80,81,82,83], and the high feedback we have noted of joint noises in pregnant women.
Relaxin, which is mainly found in serum and mammalian tissues, especially during pregnancy, has a series of actions that together promote gestation and prepare the female reproductive apparatus for childbirth. The connective tissue of pubic symphyses causes the transformation from cartilage to the more fluid and flexible with ligament formation between the two pubic bones. They increase collagen texture and extensibility [83,84,85] and dilate and makes the cervix softer.
On the basis of previous evidence confirming the prevalence of TMD in female [24,26,72], our findings would suggest that pregnancy can be more susceptible from TMD and that gestation is a predisposing factor for craniomandibular dysfunctions [58,59,60,61,62,63].
The hypothesis that relaxin, reaching high levels during pregnancy, affects the tenderness of joint tissues, including the TMJ [74,75], could explain the high incidence of clicks in the pregnant young women found in the present study. Further studies, based on this assumption, are warmly required in order to provide new information on the potential effects of hormone levels on the development of TMD.
The limitation of this study is the absence of a quantitative distinction between physical assessment and psychological assessment of TMD and further studies should include this comparative evaluation in the methodology.

5. Conclusions

Female subjects in pregnancy status could be more susceptible to TMD due to a physiological increment of estrogenic hormones levels. However, further studies are needed to better understand the role of TMD during pregnancy.

Author Contributions

G.F. has drafted the work and performed segmentations; A.P. and S.S. has performed the experimental procedures; G.P. and F.I. has validated the results. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Furquim, B.D.; Flamengui, L.M.; Conti, P.C. TMD and chronic pain: A current view. Dent. Press J. Orthod. 2015, 20, 127–133. [Google Scholar] [CrossRef] [PubMed]
  2. Castelo, P.M.; Gaviao, M.B.; Pereira, L.J.; Bonjardim, L.R. Relationship between oral parafunctional/nutritive sucking habits and temporomandibular joint dysfunction in primary dentition. Int. J. Paediatr. Dent. 2005, 15, 29–36. [Google Scholar] [CrossRef] [PubMed]
  3. Mackie, A.; Lyons, K. The role of occlusion in temporomandibular disorders--a review of the literature. N. Z. Dent. J. 2008, 104, 54–59. [Google Scholar] [PubMed]
  4. Okeson, J.P. Management of Temporomandibular Disorder and Occlusion -E -Book; Elsevier Health Sciences: Amsterdam, The Netherlands, 2008; pp. 1–333. [Google Scholar] [CrossRef]
  5. Chisnoiu, A.M.; Chisnoiu, R.; Moldovan, M.; Lascu, L.M.; Picos, A.M. Etiological factors associated with temporomandibular joint disorder - Study on animal model. Rom. J. Morphol. Embryol. 2016, 57, 185–189. [Google Scholar] [PubMed]
  6. Mortazavi, S.H.; Motamedi, M.H.; Navi, F.; Pourshahab, M.; Bayanzadeh, S.M.; Hajmiragha, H.; Isapour, M. Outcomes of management of early temporomandibular joint disorders: How effective is nonsurgical therapy in the long-term? Natl. J. Maxillofac. Surg. 2010, 1, 108–111. [Google Scholar]
  7. Lo Giudice, A.; Rustico, L.; Caprioglio, A.; Migliorati, M.; Nucera, R. Evaluation of condylar cortical bone thickness in patient groups with different vertical facial dimensions using cone-beam computed tomography. Odontology 2020. [Google Scholar] [CrossRef]
  8. Lo Giudice, A.; Brewer, I.; Leonardi, R.; Roberts, N.; Bagnato, G. Pain threshold and temporomandibular function in systemic sclerosis: Comparison with psoriatic arthritis. Clin. Rheumatol. 2018, 37, 1861–1867. [Google Scholar] [CrossRef]
  9. Ferendiuk, E.; Zajdel, K.; Pihut, M. Incidence of otolaryngological symptoms in patients with temporomandibular joint dysfunctions. Biomed Res. Int. 2014, 2014, 824684. [Google Scholar] [CrossRef] [Green Version]
  10. Velly, A.M.; Schiffman, E.L.; Rindal, D.B.; Cunha-Cruz, J.; Gilbert, G.H.; Lehmann, M.; Horowitz, A.; Fricton, J. The feasibility of a clinical trial of pain related to temporomandibular muscle and joint disorders: The results of a survey from the Collaboration on Networked Dental and Oral Research dental practice-based research networks. J. Am. Dent. Assoc. 2013, 144, e1–e10. [Google Scholar] [CrossRef]
  11. Leonardi, R.; Loreto, C.; Talic, N.; Caltabiano, R.; Musumeci, G. Immunolocalization of lubricin in the rat periodontal ligament during experimental tooth movement. Acta Histochem. 2012, 114, 700–704. [Google Scholar] [CrossRef]
  12. Loreto, C.; Leonardi, R.; Musumeci, G.; Pannone, G.; Castorina, S. An ex vivo study on immunohistochemical localization of MMP-7 and MMP-9 in temporomandibular joint discs with internal derangement. Eur. J. Histochem. 2013, 57, e12. [Google Scholar] [CrossRef] [Green Version]
  13. Musumeci, G.; Castrogiovanni, P.; Leonardi, R.; Trovato, F.M.; Szychlinska, A.; Di Giunta, A.; Loreto, C.; Castorina, S. New perspectives for articular cartilage repair treatment through tissue engineering: A contemporary review. World J. Orthop. 2014, 18, 80–88. [Google Scholar] [CrossRef] [Green Version]
  14. Musumeci, G.; Trovato, F.M.; Loreto, C.; Leonardi, R.; Szychlinska, M.A.; Castorina, S.; Mobasheri, A. Lubricin expression in human osteoarthritic knee meniscus and synovial fluid: A morphological, immunohistochemical and biochemical study. Acta Histochem. 2014, 116, 965–972. [Google Scholar] [CrossRef] [PubMed]
  15. Cavuoti, S.; Matarese, G.; Isola, G.; Abdolreza, J.; Femiano, F.; Perillo, L. Combined orthodontic-surgical management of a transmigrated mandibular canine. Angle Orthod. 2016, 86, 681–691. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Leonardi, R.; Perrotta, R.E.; Almeida, L.E.; Loreto, C.; Musumeci, G. Lubricin in synovial fluid of mild and severe temporomandibular joint internal derangements. Med. Oral Patol. Oral Cir. Bucal. 2016, 21, e793–e799. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Szychlinska, M.A.; Trovato, F.M.; Di Rosa, M.; Malaguarnera, L.; Puzzo, L.; Leonardi, R.; Castrogiovanni, P.; Musumeci, G. Co-Expression and Co-Localization of Cartilage Glycoproteins CHI3L1 and Lubricin in Osteoarthritic Cartilage: Morphological, Immunohistochemical and Gene Expression Profiles. Int. J. Mol. Sci. 2016, 17, 359. [Google Scholar] [CrossRef]
  18. Loreto, C.; Chiarenza, G.P.; Musumeci, G.; Castrogiovanni, P.; Imbesi, R.; Ruggeri, A.; Almeida, L.E.; Leonardi, R.; Leonardi, R. ADAM10 localization in temporomandibular joint disk with internal derangement: An ex vivo immunohistochemical study. Acta Histochem. 2016, 118, 293–298. [Google Scholar] [CrossRef] [Green Version]
  19. Leonardi, R.; Perrotta, R.E.; Loreto, C.; Musumeci, G.; Crimi, S.; Dos Santos, J.N.; Rusu, M.C.; Bufo, P.; Barbato, E.; Pannone, G. Toll-like Receptor 4 Expression in the Epithelium of Inflammatory Periapical Lesions. An Immunohistochemical Study. Eur. J. Histochem. 2015, 59, 2547. [Google Scholar] [CrossRef] [Green Version]
  20. Leonardi, R.; Lo Giudice, A.; Rugeri, M.; Muraglie, S.; Cordasco, G.; Barbato, E. Three-dimensional evaluation on digital casts of maxillary palatal size and morphology in patients with functional posterior crossbite. Eur. J. Orthod. 2018, 40, 556–562. [Google Scholar] [CrossRef]
  21. Lo Giudice, A.; Fastuca, R.; Portelli, M.; Militi, A.; Bellocchio, M.; Spinuzza, P.; Briguglio, F.; Caprioglio, A.; Nucera, R. Effects of rapid vs slow maxillary expansion on nasal cavity dimensions in growing subjects: A methodological and reproducibility study. Eur. J. Paediatr. Dent. 2017, 18, 299–304. [Google Scholar] [CrossRef]
  22. Koidis, P.T.; Zarifi, A.; Grigoriadou, E.; Garefis, P. Effect of age and sex on craniomandibular disorders. J. Prosthet. Dent. 1993, 69, 93–101. [Google Scholar] [CrossRef]
  23. Leonardi, R.; Loreto, C.; Barbato, E.; Polimeni, A.; Caltabiano, R.; Lo Muzio, L. A histochemical survey of the human temporomandibular joint disc of patients with internal derangement without reduction. J. Craniofac. Surg. 2007, 18, 1429–1433. [Google Scholar] [CrossRef] [PubMed]
  24. Cutroneo, G.; Piancino, M.G.; Ramieri, G.; Bracco, P.; Vita, G.; Isola, G.; Vermiglio, G.; Favaloro, A.; Anastasi, G.P.; Trimarchi, F. Expression of muscle-specific integrins in masseter muscle fibers during malocclusion disease. Int. J. Mol. Med. 2012, 30, 235–242. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Almeida, L.E.; Pierce, S.; Zacharias, J.; Cullinan, W.; Noronha, L.; Olandoski, M.; Tramontina, V.; Loreto, C.; Leonardi, R. Immunohistochemical analysis of IL-1 beta in the discs of patients with temporomandibular joint dysfunction. Cranio 2017, 35, 233–237. [Google Scholar] [CrossRef]
  26. Leonardi, R.; Muraglie, S.; Crimi, S.; Pirroni, M.; Musumeci, G.; Perrotta, R. Morphology of palatally displaced canines and adjacent teeth, a 3-D evaluation from cone-beam computed tomographic images. BMC Oral Health 2018, 18, 156. [Google Scholar] [CrossRef] [Green Version]
  27. Almeida, L.E.; Hresko, K.; Sorenson, A.; Butcher, S.; Tayebi, L.; Leonardi, R.; Loreto, C.; Bosio, J.; Camejo, F.; Doetzer, A. Immunohistochemical expression of TLR-4 in temporomandibular joint dysfunction. Cranio 2019, 37, 323–328. [Google Scholar] [CrossRef] [Green Version]
  28. Di Rosa, M.; Szychlinska, M.A.; Tibullo, D.; Malaguarnera, L.; Musumeci, G. Expression of CHI3L1 and CHIT1 in osteoarthritic rat cartilage model. A morphological study. Eur. J. Histochem. 2014, 58, 2423. [Google Scholar] [CrossRef] [Green Version]
  29. Isola, G.; Polizzi, A.; Santonocito, S.; Alibrandi, A.; Ferlito, S. Expression of salivary and serum malondialdehyde and lipid profile of patients with periodontitis and coronary heart disease. Int. J. Mol. Sci. 2019, 20, 6061. [Google Scholar] [CrossRef] [Green Version]
  30. Lo Giudice, A.; Ortensi, L.; Farronato, M.; Lucchese, A.; Lo Castro, A.; Isola, G. The step further smile virtual planning: Milled versus prototyped mock-ups for the evaluation of the designed smile characteristics. A comparative study in the aesthetic area using surface-to-surface matching technique. BMC Oral Health 2020, 20, 166. [Google Scholar]
  31. Isola, G.; Alibrandi, A.; Pedulla, E.; Grassia, V.; Ferlito, S.; Perillo, L.; Rapisarda, E. Analysis of the effectiveness of lornoxicam and flurbiprofen on management of pain and sequelae following third molar surgery: A randomized, controlled, clinical trial. J. Clin. Med. 2019, 8, 325. [Google Scholar] [CrossRef] [Green Version]
  32. Isola, G.; Matarese, G.; Alibrandi, A.; Dalessandri, D.; Migliorati, M.; Pedulla, E.; Rapisarda, E. Comparison of effectiveness of etoricoxib and diclofenac on pain and perioperative sequelae after surgical avulsion of mandibular third molars: A randomized, controlled, clinical trial. Clin. J. Pain 2019, 35, 908–915. [Google Scholar] [CrossRef] [PubMed]
  33. Isola, G.; Perillo, L.; Migliorati, M.; Matarese, M.; Dalessandri, D.; Grassia, V.; Alibrandi, A.; Matarese, G. The impact of temporomandibular joint arthritis on functional disability and global health in patients with juvenile idiopathic arthritis. Eur. J. Orthod. 2019, 41, 117–124. [Google Scholar] [CrossRef]
  34. Loreto, C.; Filetti, V.; Almeida, L.E.; La Rosa, G.R.M.; Leonardi, R.; Grippaudo, C.; Lo Giudice, A. MMP-7 and MMP-9 are overexpressed in the synovial tissue from severe temporomandibular joint dysfunction. Eur. J. Histochem. 2020, 64. [Google Scholar] [CrossRef] [PubMed]
  35. Ferlazzo, N.; Curro, M.; Zinellu, A.; Caccamo, D.; Isola, G.; Ventura, V.; Carru, C.; Matarese, G.; Ientile, R. Influence of MTHFR genetic background on p16 and MGMT methylation in oral squamous cell cancer. Int. J. Mol. Sci. 2017, 18, 724. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Puri, J.; Hutchins, B.; Bellinger, L.L.; Kramer, P.R. Estrogen and inflammation modulate estrogen receptor alpha expression in specific tissues of the temporomandibular joint. Reprod. Biol. Endocrinol. 2009, 7, 155. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Papka, R.E.; Srinivasan, B.; Miller, K.E.; Hayashi, S. Localization of estrogen receptor protein and estrogen receptor messenger RNA in peripheral autonomic and sensory neurons. Neuroscience 1997, 79, 1153–1163. [Google Scholar] [CrossRef]
  38. Wang, J.; Chao, Y.; Wan, Q.; Zhu, Z. The possible role of estrogen in the incidence of temporomandibular disorders. Med. Hypotheses 2008, 71, 564–567. [Google Scholar] [CrossRef]
  39. Bettini, E.; Pollio, G.; Santagati, S.; Maggi, A. Estrogen receptor in rat brain: Presence in the hippocampal formation. Neuroendocrinology 1992, 56, 502–508. [Google Scholar] [CrossRef]
  40. Castrogiovanni, P.; Trovato, F.M.; Szychlinska, M.A.; Nsir, H.; Imbesi, R.; Musumeci, G. The importance of physical activity in osteoporosis. From the molecular pathways to the clinical evidence. Histol. Histopathol. 2016, 31, 1183–1194. [Google Scholar] [CrossRef]
  41. Helkimo, M. Studies on function and dysfunction of the masticatory system. 3. Analyses of anamnestic and clinical recordings of dysfunction with the aid of indices. Swed. Dent. J. 1974, 67, 165–181. [Google Scholar]
  42. Lo Giudice, A.; Nucera, R.; Leonardi, R.; Paiusco, A.; Baldoni, M.; Caccianiga, G. A comparative assessment of the efficiency of orthodontic treatment with and without photobiomodulation during mandibular decrowding in young subjects: A single-center, single-blind randomized controlled trial. Photobiomodul. Photomed. Laser Surg. 2020. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Lo Giudice, A.; Nucera, R.; Perillo, L.; Paiusco, A.; Caccianiga, G. Is Low-level laser therapy an effective method to alleviate pain induced by active orthodontic alignment archwire? A Randomized clinical trial. J. Evid. Based Dent. Pract. 2019, 19, 71–78. [Google Scholar] [CrossRef] [PubMed]
  44. Mayoral, V.A.; Espinosa, I.A.; Montiel, A.J. Association between signs and symptoms of temporomandibular disorders and pregnancy (case control study). Acta Odontol. Latinoam. 2013, 26, 3–7. [Google Scholar] [PubMed]
  45. Woodrow, K.M.; Friedman, G.D.; Siegelaub, A.B.; Collen, M.F. Pain tolerance: Differences according to age, sex and race. Psychosom. Med. 1972, 34, 548–556. [Google Scholar] [CrossRef] [PubMed]
  46. Procacci, P.; Zoppi, M.; Maresca, M.; Romano, S. Studies on the pain threshold in man. Adv. Neurol. 1974, 4, 107–113. [Google Scholar]
  47. Perillo, L.; Isola, G.; Esercizio, D.; Iovane, M.; Triolo, G.; Matarese, G. Differences in craniofacial characteristics in Southern Italian children from Naples: A retrospective study by cephalometric analysis. Eur. J. Paediatr. Dent. 2013, 14, 195–198. [Google Scholar]
  48. Isola, G.; Alibrandi, A.; Rapisarda, E.; Matarese, G.; Williams, R.C.; Leonardi, R. Association of vitamin D in patients with periodontitis: A cross-sectional study. J. Periodontal Res. 2020. [Google Scholar] [CrossRef]
  49. Isola, G.; Giudice, A.L.; Polizzi, A.; Alibrandi, A.; Patini, R.; Ferlito, S. Periodontitis and tooth loss have negative systemic impact on circulating progenitor cell levels: A Clinical study. Genes 2019, 10, 1022. [Google Scholar] [CrossRef] [Green Version]
  50. Isola, G.; Matarese, G.; Ramaglia, L.; Pedulla, E.; Rapisarda, E.; Iorio-Siciliano, V. Association between periodontitis and glycosylated haemoglobin before diabetes onset: A cross-sectional study. Clin. Oral Investig. 2019. [Google Scholar] [CrossRef]
  51. Isola, G.; Polizzi, A.; Alibrandi, A.; Indelicato, F.; Ferlito, S. Analysis of Endothelin-1 Concentrations in individuals with periodontitis. Sci. Rep. 2020, 10, 1652. [Google Scholar] [CrossRef]
  52. Isola, G.; Polizzi, A.; Muraglie, S.; Leonardi, R.; Lo Giudice, A. Assessment of Vitamin C and Antioxidant profiles in saliva and serum in patients with periodontitis and ischemic heart disease. Nutrients 2019, 11, 2956. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Curro, M.; Matarese, G.; Isola, G.; Caccamo, D.; Ventura, V.P.; Cornelius, C.; Lentini, M.; Cordasco, G.; Ientile, R. Differential expression of transglutaminase genes in patients with chronic periodontitis. Oral Dis. 2014, 20, 616–623. [Google Scholar] [CrossRef] [PubMed]
  54. Briguglio, F.; Briguglio, E.; Briguglio, R.; Cafiero, C.; Isola, G. Treatment of infrabony periodontal defects using a resorbable biopolymer of hyaluronic acid: A randomized clinical trial. Quintessence Int. 2013, 44, 231–240. [Google Scholar] [CrossRef] [PubMed]
  55. Lupton, D.E. Psychological aspects of temporomandibular joint dysfunction. J. Am. Dent. Assoc. 1969, 79, 131–136. [Google Scholar] [CrossRef]
  56. Molin, C.; Schalling, D.; Edman, G. Psychological studies of patients with mandibular pain dysfunction syndrome. 1. Personality traits in patients and controls. Sven. Tandlak. Tidskr. 1973, 66, 1–13. [Google Scholar]
  57. Matarese, G.; Curro, M.; Isola, G.; Caccamo, D.; Vecchio, M.; Giunta, M.L.; Ramaglia, L.; Cordasco, G.; Williams, R.C.; Ientile, R. Transglutaminase 2 up-regulation is associated with RANKL/OPG pathway in cultured HPDL cells and THP-1-differentiated macrophages. Amino Acids 2015, 47, 2447–2455. [Google Scholar] [CrossRef]
  58. Reiter, S.; Eli, I.; Mahameed, M.; Emodi-Perlman, A.; Friedman-Rubin, P.; Reiter, M.A.; Winocur, E. Pain catastrophizing and pain persistence in temporomandibular disorder patients. J. Oral Facial Pain Headache 2018, 32, 309–320. [Google Scholar] [CrossRef]
  59. Musumeci, G.; Magro, G.; Cardile, V.; Coco, M.; Marzagalli, R.; Castrogiovanni, P.; Imbesi, R.; Graziano, A.C.; Barone, F.; Di Rosa, M.; et al. Characterization of matrix metalloproteinase-2 and -9, ADAM-10 and N-cadherin expression in human glioblastoma multiforme. Cell Tissue Res. 2015, 362, 45–60. [Google Scholar] [CrossRef]
  60. Piancino, M.G.; Isola, G.; Cannavale, R.; Cutroneo, G.; Vermiglio, G.; Bracco, P.; Anastasi, G.P. From periodontal mechanoreceptors to chewing motor control: A systematic review. Arch. Oral Biol. 2017, 78, 109–121. [Google Scholar] [CrossRef]
  61. Matarese, G.; Isola, G.; Anastasi, G.P.; Favaloro, A.; Milardi, D.; Vermiglio, G.; Vita, G.; Cordasco, G.; Cutroneo, G. Immunohistochemical analysis of TGF-beta1 and VEGF in gingival and periodontal tissues: A role of these biomarkers in the pathogenesis of scleroderma and periodontal disease. Int. J. Mol. Med. 2012, 30, 502–508. [Google Scholar] [CrossRef] [Green Version]
  62. Lo Giudice, A.; Caccianiga, G.; Crimi, S.; Cavallini, C.; Leonardi, R. Frequency and type of ponticulus posticus in a longitudinal sample of nonorthodontically treated patients: Relationship with gender, age, skeletal maturity, and skeletal malocclusion. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2018, 126, 291–297. [Google Scholar] [CrossRef] [PubMed]
  63. Sassarini, D.J. Depression in midlife women. Maturitas 2016, 94, 149–154. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  64. Iwasaki, L.R.; Gonzalez, Y.M.; Liu, Y.; Liu, H.; Markova, M.; Gallo, L.M.; Nickel, J.C. TMJ energy densities in healthy men and women. Osteoarthr. Cartil. 2017, 25, 846–849. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  65. Huhtela, O.S.; Näpänkangas, R.; Joensuu, T.; Raustia, A.; Kunttu, K.; Sipilä, K. Self-Reported Bruxism and symptoms of temporomandibular disorders in Finnish University students. J. Oral Facial Pain Headache 2016, 30, 311–317. [Google Scholar] [CrossRef]
  66. Isola, G.; Matarese, M.; Briguglio, F.; Grassia, V.; Picciolo, G.; Fiorillo, L.; Matarese, G. Eectiveness of Low-Level Laser Therapy during Tooth Movement: A Randomized Clinical Trial. Materials 2019, 12, 2187. [Google Scholar] [CrossRef] [Green Version]
  67. Vannuccini, S.; Bocchi, C.; Severi, F.M.; Challis, J.R.; Petraglia, F. Endocrinology of human parturition. Ann. D’endocrinologie 2016, 77, 105–113. [Google Scholar] [CrossRef]
  68. Isola, G.; Matarese, M.; Ramaglia, L.; Cicciu, M.; Matarese, G. Evaluation of the efficacy of celecoxib and ibuprofen on postoperative pain, swelling, and mouth opening after surgical removal of impacted third molars: A randomized, controlled clinical trial. Int. J. Oral Maxillofac. Surg. 2019, 48, 1348–1354. [Google Scholar] [CrossRef]
  69. Goh, W.A.; Zalud, I. Placenta accreta: Diagnosis, management and the molecular biology of the morbidly adherent placenta. J. Matern. Fetal Neonatal Med. 2016, 29, 1795–1800. [Google Scholar] [CrossRef] [Green Version]
  70. Matarese, G.; Isola, G.; Ramaglia, L.; Dalessandri, D.; Lucchese, A.; Alibrandi, A.; Fabiano, F.; Cordasco, G. Periodontal biotype: Characteristic, prevalence and dimensions related to dental malocclusion. Minerva Stomatol. 2016, 65, 231–238. [Google Scholar]
  71. Cannavale, R.; Matarese, G.; Isola, G.; Grassia, V.; Perillo, L. Early treatment of an ectopic premolar to prevent molar-premolar transposition. Am. J. Orthod. Dentofac. Orthop. 2013, 143, 559–569. [Google Scholar] [CrossRef]
  72. Isola, G.; Matarese, M.; Ramaglia, L.; Iorio-Siciliano, V.; Cordasco, G.; Matarese, G. Efficacy of a drug composed of herbal extracts on postoperative discomfort after surgical removal of impacted mandibular third molar: A randomized, triple-blind, controlled clinical trial. Clin. Oral Investig. 2019, 23, 2443–2453. [Google Scholar] [CrossRef] [PubMed]
  73. Leonardi, R.; Almeida, L.E.; Trevilatto, P.C.; Loreto, C. Occurrence and regional distribution of TRAIL and DR5 on temporomandibular joint discs: Comparison of disc derangement with and without reduction. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2010, 109, 244–251. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  74. Matarese, G.; Isola, G.; Anastasi, G.P.; Cutroneo, G.; Favaloro, A.; Vita, G.; Cordasco, G.; Milardi, D.; Zizzari, V.L.; Tetè, S.; et al. Transforming Growth Factor Beta 1 and Vascular Endothelial Growth Factor levels in the pathogenesis of periodontal disease. Eur. J. Inflamm. 2013, 11, 479–488. [Google Scholar] [CrossRef] [Green Version]
  75. Trenti, A.; Tedesco, S.; Boscaro, C.; Trevisi, L.; Bolego, C.; Cignarella, A. Estrogen, Angiogenesis, immunity and cell metabolism: Solving the puzzle. Int. J. Mol. Sci. 2018, 19, 859. [Google Scholar] [CrossRef] [Green Version]
  76. Isola, G.; Anastasi, G.P.; Matarese, G.; Williams, R.C.; Cutroneo, G.; Bracco, P.; Piancino, M.G. Functional and molecular outcomes of the human masticatory muscles. Oral Dis. 2018, 24, 1428–1441. [Google Scholar] [CrossRef] [PubMed]
  77. Lo Muzio, L.; Campisi, G.; Farina, A.; Rubini, C.; Pastore, L.; Giannone, N.; Colella, G.; Leonardi, R.; Carinci, F. Effect of p63 expression on survival in oral squamous cell carcinoma. Cancer Investig. 2007, 25, 464–469. [Google Scholar] [CrossRef]
  78. Isola, G.; Alibrandi, A.; Curro, M.; Matarese, M.; Ricca, S.; Matarese, G.; Ientile, R.; Kocher, T. Evaluation of salivary and serum ADMA levels in patients with periodontal and cardiovascular disease as subclinical marker of cardiovascular risk. J. Periodontol. 2020. [Google Scholar] [CrossRef]
  79. Aufdemorte, T.B.; Van Sickels, J.E.; Dolwick, M.F.; Sheridan, P.J.; Holt, G.R.; Aragon, S.B.; Gates, G.A. Estrogen receptors in the temporomandibular joint of the baboon (Papio cynocephalus): An autoradiographic study. Oral Surg. Oral Med. Oral Pathol. 1986, 61, 307–314. [Google Scholar] [CrossRef]
  80. Perillo, L.; Padricelli, G.; Isola, G.; Femiano, F.; Chiodini, P.; Matarese, G. Class II malocclusion division 1: A new classification method by cephalometric analysis. Eur. J. Paediatr. Dent. 2012, 13, 192–196. [Google Scholar]
  81. Sorenson, A.; Hresko, K.; Butcher, S.; Pierce, S.; Tramontina, V.; Leonardi, R.; Loreto, C.; Bosio, J.; Almeida, L.E. Expression of Interleukin-1 and temporomandibular disorder: Contemporary review of the literature. Cranio 2018, 36, 268–272. [Google Scholar] [CrossRef] [Green Version]
  82. Isola, G.; Polizzi, A.; Iorio-Siciliano, V.; Alibrandi, A.; Ramaglia, L.; Leonardi, R. Effectiveness of a nutraceutical agent in the non-surgical periodontal therapy: A randomized, controlled clinical trial. Clin. Oral Investig. 2020, in press 7 June. [Google Scholar]
  83. Nucera, R.; Militi, A.; Lo Giudice, A.; Longo, V.; Fastuca, R.; Caprioglio, A.; Cordasco, G.; Papadopoulos, M.A. Skeletal and Dental Effectiveness of Treatment of Class II Malocclusion With Headgear: A Systematic Review and Meta-analysis. J Evid. Based. Dent. Pract. 2018, 18, 41–58. [Google Scholar] [CrossRef] [PubMed]
  84. Fiorillo, L. Spine and TMJ: A Pathophysiology report. J. Funct. Morphol. Kinesiol. 2020, 5, 24. [Google Scholar] [CrossRef] [Green Version]
  85. Fiorillo, L.; Musumeci, G. TMJ Dysfunction and Systemic Correlation. J. Funct. Morphol. Kinesiol. 2020, 5, 20. [Google Scholar] [CrossRef] [Green Version]
Figure 1. Example of the anamnestic Helkimo index.
Figure 1. Example of the anamnestic Helkimo index.
Jfmk 05 00036 g001
Figure 2. Example of the Helkimo clinical dysfunction index questionnaire filled out by one included patient.
Figure 2. Example of the Helkimo clinical dysfunction index questionnaire filled out by one included patient.
Jfmk 05 00036 g002
Table 1. Data distribution from the anamnestic form (Helkimo’s index). Significance set at p < 0.05 according to the Chi-Square test.
Table 1. Data distribution from the anamnestic form (Helkimo’s index). Significance set at p < 0.05 according to the Chi-Square test.
TMJ Disfunction
PositiveNegativeTotal
Study GroupObserved8721108p < 0.05
Percentage (%)8119100
Study GroupObserved474390
Percentage (%)5248100
Table 2. Data distribution from the anamnestic form (Helkimo’s index). Significance set at p < 0.05 according to the Chi-Square test.
Table 2. Data distribution from the anamnestic form (Helkimo’s index). Significance set at p < 0.05 according to the Chi-Square test.
Articular SignsMuscular PainTotal
Study GroupObserved87087p < 0.05
Percentage (%)1000100
Study GroupObserved371047
Percentage (%)7921100

Share and Cite

MDPI and ACS Style

Fichera, G.; Polizzi, A.; Scapellato, S.; Palazzo, G.; Indelicato, F. Craniomandibular Disorders in Pregnant Women: An Epidemiological Survey. J. Funct. Morphol. Kinesiol. 2020, 5, 36. https://doi.org/10.3390/jfmk5020036

AMA Style

Fichera G, Polizzi A, Scapellato S, Palazzo G, Indelicato F. Craniomandibular Disorders in Pregnant Women: An Epidemiological Survey. Journal of Functional Morphology and Kinesiology. 2020; 5(2):36. https://doi.org/10.3390/jfmk5020036

Chicago/Turabian Style

Fichera, Grazia, Alessandro Polizzi, Simone Scapellato, Giuseppe Palazzo, and Francesco Indelicato. 2020. "Craniomandibular Disorders in Pregnant Women: An Epidemiological Survey" Journal of Functional Morphology and Kinesiology 5, no. 2: 36. https://doi.org/10.3390/jfmk5020036

Article Metrics

Back to TopTop